Tobacco Use and Nicotine Dependence Among HIV-infected and Uninfected Injection Drug Users

Overview

Journal Addict Behav

Specialties Psychiatry
Social Sciences

Date 2010 Sep 30

PMID 20875704

Citations 41

Authors

Mariah M Marshall

Gregory D Kirk

Neil E Caporaso

Meredith C McCormack

Christian A Merlo

John C Hague

Shruti H Mehta

Eric A Engels

Affiliations

Soon will be listed here.

Abstract

Introduction: Urban U.S. populations are burdened by intersecting epidemics of HIV infection, injection drug use, and cigarette smoking. Given the substantial morbidity attributable to tobacco in these populations, we characterized smoking behaviors, nicotine addiction, and tobacco exposure among HIV-infected and HIV-uninfected injection drug users (IDUs) in Baltimore, Maryland.

Methods: Smoking behaviors among participants in the ALIVE Study were assessed using interviewer-administered questionnaires. Smoking history and nicotine dependence (Fagerstrom Index scores) were compared by HIV and drug injecting status. Serum cotinine (a nicotine metabolite) was measured for a sample of participants by enzyme immunoassay.

Results: Among 1052 participants (29.7% HIV-infected, 39.8% active injectors), 85.2% were current smokers and 9.3% were former smokers. Smoking prevalence, age at smoking initiation, and cumulative tobacco exposure were similar by HIV status. Median Fagerstrom scores of 4 for HIV-infected and HIV-uninfected smokers indicated moderate nicotine dependence. Daily cigarette consumption was identical by HIV status (median 10 cigarettes), although HIV-infected participants were less likely to smoke 1+ pack daily compared to HIV-uninfected participants (18.0% vs. 26.9%, p=0.001). Compared to former injectors, active injectors had higher smoking prevalence (90.5% vs. 81.7%, p=0.0001), greater daily cigarette consumption (30.7% vs. 19.6% smoked 1+ pack daily, p=0.0001), and slightly higher Fagerstrom scores (median 5 vs. 4). Cotinine levels paralleled self-reported cigarette consumption.

Discussion: Tobacco use is extremely common among inner-city IDUs. Smoking behavior and nicotine dependence did not materially differ by HIV status but were associated with active drug injection. Cessation efforts should target the dual dependence of cigarettes and drugs experienced among this population.

Citing Articles

Comparison of smoking behaviors and associated factors between HIV-infected and uninfected men in Guilin, China: a case-control study.

Yu Y, Xiao F, Xia M, Huang L, Liu X, Tang W Front Psychol. 2025; 15():1422144.

PMID: 39776966 PMC: 11705868. DOI: 10.3389/fpsyg.2024.1422144.

Nicotine is an Immunosuppressant: Implications for Women's Health and Disease.

White A, Craig A, Richie D, Corley C, Sadek S, Barton H J Neuroimmunol. 2024; 397:578468.

PMID: 39461120 PMC: 11653054. DOI: 10.1016/j.jneuroim.2024.578468.

Baltimore oral epidemiology, disease effects, and HIV evaluation study (BEEHIVE) study protocol: a prospective cohort study.

Weatherspoon D, Kirk G, Piggott D, Thumbigere-Math V, Dye B, Macek M BMC Oral Health. 2024; 24(1):439.

PMID: 38600460 PMC: 11008028. DOI: 10.1186/s12903-024-04200-1.

Liu Z, Chen X, Li J, Xie Z, Huang Y, Luo D Front Public Health. 2023; 11:1163604.

PMID: 37377546 PMC: 10291293. DOI: 10.3389/fpubh.2023.1163604.

HCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 HEPAVIH Cohort Study).

Barre T, Mercie P, Marcellin F, Esterle L, Duvivier C, Teicher E AIDS Behav. 2021; 25(12):4141-4153.

PMID: 33903998 DOI: 10.1007/s10461-021-03277-x.

References

Diaz P, Clanton T, Pacht E . Emphysema-like pulmonary disease associated with human immunodeficiency virus infection. Ann Intern Med. 1992; 116(2):124-8. DOI: 10.7326/0003-4819-116-2-124. View

Friis-Moller N, Weber R, Reiss P, Thiebaut R, Kirk O, Monforte A . Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study. AIDS. 2003; 17(8):1179-93. DOI: 10.1097/01.aids.0000060358.78202.c1. View

John U, Meyer C, Hapke U, Rumpf H, Schumann A, Adam C . The Fagerström test for nicotine dependence in two adult population samples-potential influence of lifetime amount of tobacco smoked on the degree of dependence. Drug Alcohol Depend. 2003; 71(1):1-6. DOI: 10.1016/s0376-8716(03)00038-3. View

Berthiller J, Straif K, Boniol M, Voirin N, Benhaim-Luzon V, Ayoub W . Cannabis smoking and risk of lung cancer in men: a pooled analysis of three studies in Maghreb. J Thorac Oncol. 2008; 3(12):1398-403. DOI: 10.1097/JTO.0b013e31818ddcde. View

Lewden C, Salmon D, Morlat P, Bevilacqua S, Jougla E, Bonnet F . Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2004; 34(1):121-30. DOI: 10.1093/ije/dyh307. View

Frikart M, Etienne S, Cornuz J, Zellweger J . Five-day plan for smoking cessation using group behaviour therapy. Swiss Med Wkly. 2003; 133(3-4):39-43. DOI: 10.4414/smw.2003.10068. View

Pirkle J, Flegal K, Bernert J, Brody D, Etzel R, Maurer K . Exposure of the US population to environmental tobacco smoke: the Third National Health and Nutrition Examination Survey, 1988 to 1991. JAMA. 1996; 275(16):1233-40. View

Clemmey P, Brooner R, Chutuape M, Kidorf M, Stitzer M . Smoking habits and attitudes in a methadone maintenance treatment population. Drug Alcohol Depend. 1997; 44(2-3):123-32. DOI: 10.1016/s0376-8716(96)01331-2. View

Chaturvedi A, Pfeiffer R, Chang L, Goedert J, Biggar R, Engels E . Elevated risk of lung cancer among people with AIDS. AIDS. 2007; 21(2):207-13. DOI: 10.1097/QAD.0b013e3280118fca. View

10.

Thompson S, Nanni C, Levine A . The stressors and stress of being HIV-positive. AIDS Care. 1996; 8(1):5-14. DOI: 10.1080/09540129650125957. View

11.

Kirk G, Merlo C, O Driscoll P, Mehta S, Galai N, Vlahov D . HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis. 2007; 45(1):103-10. PMC: 4078722. DOI: 10.1086/518606. View

12.

Diaz P, King M, Pacht E, Wewers M, Gadek J, Nagaraja H . Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med. 2000; 132(5):369-72. DOI: 10.7326/0003-4819-132-5-200003070-00006. View

13.

Monforte A, Sabin C, Phillips A, Sterne J, May M, Justice A . The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy. Arch Intern Med. 2005; 165(4):416-23. DOI: 10.1001/archinte.165.4.416. View

14.

Burkhalter J, Springer C, Chhabra R, Ostroff J, Rapkin B . Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res. 2005; 7(4):511-22. DOI: 10.1080/14622200500186064. View

15.

McGinnis J, FOEGE W . Mortality and morbidity attributable to use of addictive substances in the United States. Proc Assoc Am Physicians. 1999; 111(2):109-18. DOI: 10.1046/j.1525-1381.1999.09256.x. View

16.

Gritz E, Vidrine D, Lazev A, Amick 3rd B, Arduino R . Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res. 2004; 6(1):71-7. DOI: 10.1080/14622200310001656885. View

17.

Caraballo R, Giovino G, Pechacek T, Mowery P, Richter P, Strauss W . Racial and ethnic differences in serum cotinine levels of cigarette smokers: Third National Health and Nutrition Examination Survey, 1988-1991. JAMA. 1998; 280(2):135-9. DOI: 10.1001/jama.280.2.135. View

18.

Stavem K, Rogeberg O, Olsen J, Boe J . Properties of the Cigarette Dependence Scale and the Fagerström Test of Nicotine Dependence in a representative sample of smokers in Norway. Addiction. 2008; 103(9):1441-9. DOI: 10.1111/j.1360-0443.2008.02278.x. View

19.

Marshall M, McCormack M, Kirk G . Effect of cigarette smoking on HIV acquisition, progression, and mortality. AIDS Educ Prev. 2009; 21(3 Suppl):28-39. PMC: 2774230. DOI: 10.1521/aeap.2009.21.3_supp.28. View

20.

Tashkin D . Airway effects of marijuana, cocaine, and other inhaled illicit agents. Curr Opin Pulm Med. 2001; 7(2):43-61. DOI: 10.1097/00063198-200103000-00001. View